Skip to content

The effect of 12-week intake of NMN on the sleep and fatigue of community-dwelling older adults

The effect of 12-week intake of NMN on the sleep and fatigue of community-dwelling older adults - The effect of NMN intake on sleep and fatigue

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000038097
Enrollment
110
Registered
2022-01-01
Start date
2019-08-28
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy person

Interventions

Intake of NMN (253.8mg) every morning for 12 weeks (from getting up to 12 am) Intake of NMN (253.8mg) every afternoon for 12 weeks (from getting up to 12 am (from 6pm to before bedtime) Intake of plac

Sponsors

University of Tsukuba
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Subjects with the capacity to participate the study-related briefing sessions, examinations and measurements in University of Tsukuba by themselves 2) Subjects without dementia, need for long-term care service, sleep disorders or regular intake of sleeping drugs(more than once a week) depression or regular intake of anti-depressants(more than once a week) 3) Subjects with a thorough understanding of this study, and voluntary consent

Exclusion criteria

Exclusion criteria: 1) Subjects with a regular intake of sleeping drugs or anti-depressants(more than once a week) 2) Subjects with an average intake of caffeine more than 400mg per day 3) Subjects with intake of supplements, nutrition drinks or energy drinks that contain NMN or niacin (Vitamin B3, nicotinamide, nicotinic acid amide) 4) Subjects with allergies to supplements, nutrition drinks or energy drinks that contain NMN or niacin(Vitamin B3, nicotinamide, nicotinic acid amide) 5) Subjects diagnosed with chronic fatigue syndrome, sleep disorders(insomnia), mental disorders such as depression, or alcoholism and under medical treatment 6) Subjects who correspond to Not at all in category of fatigue, poor sleep or stress based on 5 level evaluation (Not at all, Slightly, Moderately, Very much, Extremely) 7) Subjects who are involving in other clinical experiments currently or having participated any other clinical experiments in the past 3 months 8) Subjects excluded as inappropriate participants by the lead principal investigator

Design outcomes

Primary

MeasureTime frame
Evaluation of Pittsburgh Sleep Quality Index(PSQI), Visual Analogue Scale(VAS) of evaluating physical fatigue and eye strain, Geriatric depression scale(GDS), Sense of Coherence(SOC) using questionnaires

Secondary

MeasureTime frame
1) Physical performance tests: Grip strength, Five times sit to stand, Timed up and go, 5m habitual walk 2) Cognitive functions: Trail Making Peg, Five cognitive function test(attention, verbal memory, visuospatial cognition, word fluency, associate learning)

Countries

Japan

Contacts

Public ContactMijin Kim

University of Tsukuba Industry-University Collaboration R&D Center for Tailor-Made QOL

mjmj0816@gmail.com029-859-2744

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026